NDRA Earnings ENDRA Life Sciences Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–7 of 7
| Q1 2026 | 2026-03-31 | -1.09 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -8.93 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -5.68 | 2025-11-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.86 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -56.94 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -82.14 | 2025-11-14 | 10-Q |
| FY 2024 | 2023-12-31 | -2766.85 | 2025-03-31 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.